111 related articles for article (PubMed ID: 10209206)
21. Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes.
Pritsker M; Rucker J; Hoffman TL; Doms RW; Shai Y
Biochemistry; 1999 Aug; 38(35):11359-71. PubMed ID: 10471286
[TBL] [Abstract][Full Text] [Related]
22. Structural analysis and assembly of the HIV-1 Gp41 amino-terminal fusion peptide and the pretransmembrane amphipathic-at-interface sequence.
Lorizate M; de la Arada I; Huarte N; Sánchez-Martínez S; de la Torre BG; Andreu D; Arrondo JL; Nieva JL
Biochemistry; 2006 Dec; 45(48):14337-46. PubMed ID: 17128972
[TBL] [Abstract][Full Text] [Related]
23. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
[TBL] [Abstract][Full Text] [Related]
24. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects.
Pereira FB; Goñi FM; Muga A; Nieva JL
Biophys J; 1997 Oct; 73(4):1977-86. PubMed ID: 9336193
[TBL] [Abstract][Full Text] [Related]
25. Solid-state nuclear magnetic resonance (NMR) spectroscopy of human immunodeficiency virus gp41 protein that includes the fusion peptide: NMR detection of recombinant Fgp41 in inclusion bodies in whole bacterial cells and structural characterization of purified and membrane-associated Fgp41.
Vogel EP; Curtis-Fisk J; Young KM; Weliky DP
Biochemistry; 2011 Nov; 50(46):10013-26. PubMed ID: 21985645
[TBL] [Abstract][Full Text] [Related]
26. A novel bispecific peptide HIV-1 fusion inhibitor targeting the N-terminal heptad repeat and fusion peptide domains in gp41.
Jiang X; Jia Q; Lu L; Yu F; Zheng J; Shi W; Cai L; Jiang S; Liu K
Amino Acids; 2016 Dec; 48(12):2867-2873. PubMed ID: 27631437
[TBL] [Abstract][Full Text] [Related]
27. Determinants of membrane activity from mutational analysis of the HIV fusion peptide.
Torres O; Bong D
Biochemistry; 2011 Jun; 50(23):5195-207. PubMed ID: 21561063
[TBL] [Abstract][Full Text] [Related]
28. HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41.
Lawless MK; Barney S; Guthrie KI; Bucy TB; Petteway SR; Merutka G
Biochemistry; 1996 Oct; 35(42):13697-708. PubMed ID: 8885850
[TBL] [Abstract][Full Text] [Related]
29. Conditional trimerization and lytic activity of HIV-1 gp41 variants containing the membrane-associated segments.
Dai Z; Tao Y; Liu N; Brenowitz MD; Girvin ME; Lai JR
Biochemistry; 2015 Mar; 54(8):1589-99. PubMed ID: 25658332
[TBL] [Abstract][Full Text] [Related]
30. Orientation and structure of the NH2-terminal HIV-1 gp41 peptide in fused and aggregated liposomes.
Martin I; Defrise-Quertain F; Decroly E; Vandenbranden M; Brasseur R; Ruysschaert JM
Biochim Biophys Acta; 1993 Jan; 1145(1):124-33. PubMed ID: 8422404
[TBL] [Abstract][Full Text] [Related]
31. The HIV fusion peptide adopts intermolecular parallel beta-sheet structure in membranes when stabilized by the adjacent N-terminal heptad repeat: a 13C FTIR study.
Sackett K; Shai Y
J Mol Biol; 2005 Jul; 350(4):790-805. PubMed ID: 15964015
[TBL] [Abstract][Full Text] [Related]
32. Efficient Fusion at Neutral pH by Human Immunodeficiency Virus gp41 Trimers Containing the Fusion Peptide and Transmembrane Domains.
Liang S; Ratnayake PU; Keinath C; Jia L; Wolfe R; Ranaweera A; Weliky DP
Biochemistry; 2018 Feb; 57(7):1219-1235. PubMed ID: 29345922
[TBL] [Abstract][Full Text] [Related]
33. HIV gp41 six-helix bundle constructs induce rapid vesicle fusion at pH 3.5 and little fusion at pH 7.0: understanding pH dependence of protein aggregation, membrane binding, and electrostatics, and implications for HIV-host cell fusion.
Sackett K; TerBush A; Weliky DP
Eur Biophys J; 2011 Apr; 40(4):489-502. PubMed ID: 21222118
[TBL] [Abstract][Full Text] [Related]
34. Investigation of human immunodeficiency virus fusion peptides. Analysis of interrelations between their structure and function.
Slepushkin VA; Andreev SM; Sidorova MV; Melikyan GB; Grigoriev VB; Chumakov VM; Grinfeldt AE; Manukyan RA; Karamov EV
AIDS Res Hum Retroviruses; 1992 Jan; 8(1):9-18. PubMed ID: 1736943
[TBL] [Abstract][Full Text] [Related]
35. Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex.
Wild C; Dubay JW; Greenwell T; Baird T; Oas TG; McDanal C; Hunter E; Matthews T
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12676-80. PubMed ID: 7809100
[TBL] [Abstract][Full Text] [Related]
36. Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion.
Suárez T; Gallaher WR; Agirre A; Goñi FM; Nieva JL
J Virol; 2000 Sep; 74(17):8038-47. PubMed ID: 10933713
[TBL] [Abstract][Full Text] [Related]
37. Role of the ectodomain of the gp41 transmembrane envelope protein of human immunodeficiency virus type 1 in late steps of the membrane fusion process.
Bär S; Alizon M
J Virol; 2004 Jan; 78(2):811-20. PubMed ID: 14694113
[TBL] [Abstract][Full Text] [Related]
38. C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.
Medinas RJ; Lambert DM; Tompkins WA
J Virol; 2002 Sep; 76(18):9079-86. PubMed ID: 12186891
[TBL] [Abstract][Full Text] [Related]
39. [Fusion of negatively-charged liposomes under the effect of peptides from the N-terminal fragment of the HIV-1 transmembrane protein].
Terletskaia IaT; Trikash IO; Serdiuk ES; Andreev SM
Biokhimiia; 1995 Oct; 60(10):1711-9. PubMed ID: 8555367
[TBL] [Abstract][Full Text] [Related]
40. HIV-1 gp41 tertiary structure studied by EPR spectroscopy.
Rabenstein MD; Shin YK
Biochemistry; 1996 Nov; 35(44):13922-8. PubMed ID: 8909289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
